Collegium Pharmaceutical, Inc.
NASDAQ:COLL
Overview | Financials
Company Name | Collegium Pharmaceutical, Inc. |
Symbol | COLL |
Currency | USD |
Price | 33.46 |
Market Cap | 1,077,873,748 |
Dividend Yield | 0% |
52-week-range | 21.4 - 42.287 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Joseph J. Ciaffoni |
Website | https://www.collegiumpharma.com |
An error occurred while fetching data.
About Collegium Pharmaceutical, Inc.
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ER for the management of pain severe enough to
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD